PREDIKTOR: Patient-centered multi-view framework aligning personalized knowledge graphs with gene-level perturbation representations for clinical drug response prediction. Combines DysRegNet GRN construction, DrugBank integration, GNN encoding, LINCS L1000 pretraining, and CLIP-style contrastive alignment.
Scanned 9/11/2026
Install to Claude Code
npx -y skills add hiyenwong/ai_collection --skill prediktor-patient-knowledge-graph-drug-response --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Prediktor Patient Knowledge Graph Drug Response?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/hiyenwong-prediktor-patient-knowledge-graph-drug-response)More formats (shields.io, HTML) on the badges page.
---
name: prediktor-patient-knowledge-graph-drug-response
description: "PREDIKTOR: Patient-centered multi-view framework aligning personalized knowledge graphs with gene-level perturbation representations for clinical drug response prediction. Combines DysRegNet GRN construction, DrugBank integration, GNN encoding, LINCS L1000 pretraining, and CLIP-style contrastive alignment."
---
# PREDIKTOR: Patient Knowledge Graph Drug Response
## Description
PREDIKTOR is a patient-centered multi-view framework that aligns a personalized network view (individualized GRN + drug-target knowledge) with a transferable transcriptomic perturbation view to predict clinical drug response. It integrates DysRegNet for patient-specific GRN construction, DrugBank for drug-target links, GNN encoding for mechanistically grounded embeddings, a frozen LINCS L1000 attention model for simulated post-perturbation profiles, and CLIP-style contrastive alignment in a shared latent space.
## Activation Keywords
- prediktor
- patient knowledge graph drug response
- personalized drug response prediction
- 患者知识图谱药物响应
- 个性化药物响应预测
- GRN drug response
- transcriptomic perturbation alignment
- precision oncology prediction
- patient-specific therapeutic response
- multi-view clinical prediction
- DysRegNet drug prediction
- CLIP alignment drug response
- I-SPY2 trial prediction
- patient-specific GRN drug
## Tools Used
- web_search: Search arXiv for related papers
- web_extract: Fetch paper details
- write: Create analysis scripts or reports
- exec: Run Python for GNN/ML pipelines
## Core Methodology
### Two-View Architecture
1. **Network View (Mechanistic)**
- Build patient-specific GRN from tumor expression using DysRegNet
- Augment GRN with drug-target links from DrugBank
- Encode with Graph Neural Network → mechanistically grounded embedding
2. **Perturbation View (Transferable)**
- Frozen condition-specific gene-gene attention model pretrained on LINCS L1000
- Generates simulated post-perturbation transcriptomic profile for patient-drug pair
- Captures drug-induced transcriptomic dynamics
### CLIP-Style Contrastive Alignment
- Align both views in shared latent space
- Use contrastive objective with drug-context hard negatives
- Concatenate aligned representations for end-to-end response classification
- Hard negatives ensure model learns drug-specific discrimination
### Key Results
- Consistently outperforms state-of-the-art baselines on TCGA
- Patient-split, drug-split, and tissue-split evaluations all show improvement
- Zero-shot transfer to I-SPY2 trial: +5.6% AUROC over competing methods
- Aligned embeddings yield stable gene and pathway attributions
- Recovers known mechanisms, supporting actionable precision oncology
## Usage Patterns
### Pattern 1: Clinical Drug Response Prediction
1. For each patient, construct individualized GRN from tumor expression (DysRegNet)
2. Augment GRN with drug-target links (DrugBank)
3. Generate simulated post-perturbation profile (frozen LINCS model)
4. Align both representations via contrastive learning
5. Classify drug response using concatenated aligned embeddings
### Pattern 2: Zero-Shot Transfer to New Trials
1. Train on source dataset (e.g., TCGA) with multi-view alignment
2. Apply to unseen trial data (e.g., I-SPY2) without fine-tuning
3. Benefit from mechanistic grounding + perturbation transferability
### Pattern 3: Interpretable Attributions
1. Extract aligned embeddings from trained model
2. Compute gene and pathway attributions
3. Verify known drug mechanisms are recovered
4. Use attributions to guide clinical decision-making
## Step-by-Step Implementation Guide
### Step 1: Patient GRN Construction
```python
# For each patient tumor sample
# Use DysRegNet to infer individualized gene regulatory network
# DysRegNet handles dysregulated GRN inference from expression data
grn = dysregnet_infer(tumor_expression, patient_id)
```
### Step 2: Knowledge Graph Augmentation
```python
# Add drug-target interactions from DrugBank
# Creates drug-centric, mechanistically grounded network
grn_drug = augment_with_drug_targets(grn, drugbank_links, drug_id)
```
### Step 3: GNN Encoding
```python
# Encode augmented GRN into embedding space
grn_embedding = gnn_encoder(grn_drug)
# Captures structural + mechanistic information
```
### Step 4: Perturbation Profile Generation
```python
# Frozen LINCS L1000 attention model
# Simulates post-perturbation transcriptomic profile
perturbation_profile = lincs_attention_model(
patient_expression, drug_id, condition
)
# Model is frozen — no gradient updates during training
```
### Step 5: CLIP-Style Alignment
```python
# Contrastive objective with hard negatives
# Hard negatives: same drug, different patient context
loss = clip_contrastive_loss(
grn_embedding, perturbation_profile,
hard_negatives=drug_context_negatives
)
```
### Step 6: Response Classification
```python
# Concatenate aligned representations
combined = concat(grn_embedding, perturbation_profile)
response_prediction = classifier(combined)
# Binary or multi-class: responder vs non-responder
```
## Error Handling
### Limited Training Labels
- **Problem**: Matched clinical response labels are scarce
- **Solution**: Pretrain perturbation view on large-scale LINCS L1000 data (no clinical labels needed)
### Cross-Site Generalization
- **Problem**: Models trained on one site may not generalize
- **Solution**: Multi-view alignment provides robustness; perturbations are transferable
### Static Knowledge Graph Limitation
- **Problem**: DrugBank is static, doesn't capture dynamics
- **Solution**: Perturbation view compensates with dynamic transcriptomic simulation
### Overfitting to Single View
- **Problem**: Either view alone may overfit
- **Solution**: Contrastive alignment enforces cross-view consistency
## Resources
- Paper: arXiv:2607.04557 — "Predicting Therapeutic Outcome via Aligning Patient-Specific Knowledge Graph and Gene-Level Perturbation Representations"
- Authors: Dongmin Bang, Sugyun An, Inyoung Sung, Ilho Yun, Sun Kim, Sangseon Lee
- Datasets: TCGA (training), I-SPY2 (zero-shot transfer)
- Key tools: DysRegNet, DrugBank, LINCS L1000, CLIP-style contrastive learning
## Related Skills
- `ai-scientific-workflow-orchestration` — AI orchestration for research workflows
- `brain-foundation-biomarker-validation` — Biomarker validation frameworks
- `medical-ai-diagnosis` — AI-based medical diagnosis patterns
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!